Encompass Health reaffirms FY2024 guidance: revenue $5.25B-$5.325B, Adj. EBITDA $1.03B-$1.065B, Adj. EPS $3.86-$4.11

Encompass Health Corp

Reiterated full-year 2024 net operating revenue guidance of $5,250M to $5,325M.
Reaffirmed Adjusted EBITDA guidance of $1,030M to $1,065M for 2024.
Adjusted diluted EPS from continuing ops expected between $3.86 and $4.11.
Fireside chat at Leerink Partners Healthcare Crossroads Conference on May 30, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.